1151 related articles for article (PubMed ID: 15912436)
21. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
22. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
23. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
[TBL] [Abstract][Full Text] [Related]
24. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
25. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
26. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
[TBL] [Abstract][Full Text] [Related]
27. The role of b-type natriuretic peptide in heart failure management.
Newton PJ; Betihavas V; Macdonald P
Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
[TBL] [Abstract][Full Text] [Related]
28. [Utility of NT-proBNP for diagnosing heart failure in a heterogeneous population of patients with dyspnea. Spanish multicenter study].
Anguita M; Montes P; Jordán A; Casares G; Gómez I; Recio J; Martínez A; Zumalde J; Povar J; Ridocci F; Roig E; Batlle E
Rev Esp Cardiol; 2006 May; 59(5):465-72. PubMed ID: 16750144
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
[TBL] [Abstract][Full Text] [Related]
30. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
31. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
[TBL] [Abstract][Full Text] [Related]
32. B-type natriuretic peptides. A diagnostic breakthrough in heart failure.
McCullough PA
Minerva Cardioangiol; 2003 Apr; 51(2):121-9. PubMed ID: 12783068
[TBL] [Abstract][Full Text] [Related]
33. Sorting out the evidence on natriuretic peptides.
McCullough PA; Sandberg KR
Rev Cardiovasc Med; 2003; 4 Suppl 4():S13-9. PubMed ID: 14564224
[TBL] [Abstract][Full Text] [Related]
34. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
35. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
36. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
[TBL] [Abstract][Full Text] [Related]
37. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
38. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
[TBL] [Abstract][Full Text] [Related]
39. Updating the role of natriuretic peptide levels in cardiovascular disease.
Gopal DJ; Iqbal MN; Maisel A
Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
McCullough PA; Omland T; Maisel AS
Rev Cardiovasc Med; 2003; 4(2):72-80. PubMed ID: 12776016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
